Lundbeck
HLUN-B.CO
#2254
Rank
A$12.10 B
Marketcap
A$12.20
Share price
0.63%
Change (1 day)
10.23%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): A$0.53

According to Lundbeck's latest financial reports the company's current EPS (TTM) is A$1.10. In 2022 the company made an earnings per share (EPS) of A$0.39 a decrease over its 2021 EPS that were of A$0.88.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A$0.5336.77%
2022A$0.39-55.47%
2021A$0.88-51.83%
2020A$1.82-28.01%
2019A$2.53-44.08%
2018A$4.5251.94%
2017A$2.97126.64%
2016A$1.31-120.84%
2015A-$6.295622.18%
2014A-$0.11-110.03%
2013A$1.10-28.08%
2012A$1.52-52.1%
2011A$3.18-1.31%
2010A$3.2215.61%
2009A$2.79